Published in
Wiley, British Journal of Dermatology, 4(181), p. 841-842, 2019
DOI: 10.1111/bjd.17926
Links
Tools
Evaluating cutaneous lupus disease activity end points and their effects on quality of life as an outcome measure for clinical trials
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 